Cargando…

The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia

Retrospective analysis of the effects of febuxostat on urine neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in patients with hyperuricemia was performed. From January 2018 to June 2018, there were 45 patients with asymptomatic hyperuricemia in the outpatient o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yushang, Liu, Tongqiang, Cai, Qiuping, Zhao, Minwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001067/ https://www.ncbi.nlm.nih.gov/pubmed/35419185 http://dx.doi.org/10.1155/2022/6028611

Ejemplares similares

Retracted: The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia
por: Healthcare Engineering, Journal of
Publicado: (2023)

Urine NGAL and KIM-1 in children and adolescents with hyperuricemia
por: Tomczak, Justyna, et al.
Publicado: (2013)

Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors
por: Latoch, Eryk, et al.
Publicado: (2020)

Early term effect of ureterorenoscopy (URS) on the Kidney: research measuring NGAL, KIM-1, FABP and CYS C levels in urine
por: Benli, Erdal, et al.
Publicado: (2017)

Value of urine IL-8, NGAL and KIM-1 for the early diagnosis of acute kidney injury in patients with ureteroscopic lithotripsy related urosepsis
por: Tan, Dan, et al.
Publicado: (2022)

Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN)
por: Liao, Baoxia, et al.
Publicado: (2019)

Urine NGAL and KIM-1—Tubular Injury Biomarkers in Long-Term Survivors of Childhood Solid Tumors: A Cross-Sectional Study
por: Latoch, Eryk, et al.
Publicado: (2021)

Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation
por: Park, Meyeon, et al.
Publicado: (2013)

KIM-1 and NGAL: new markers of obstructive nephropathy
por: Wasilewska, Anna, et al.
Publicado: (2011)

Management of hyperuricemia in gout: focus on febuxostat
por: Reinders, Mattheus K, et al.
Publicado: (2010)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus
por: Sun, In O., et al.
Publicado: (2017)

Are Tubular Injury Markers NGAL and KIM-1 Useful in Pediatric Neurogenic Bladder?
por: Bagińska, Joanna, et al.
Publicado: (2021)

Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia
por: Kario, Kazuomi, et al.
Publicado: (2021)

Febuxostat in the management of hyperuricemia and chronic gout: a review
por: Hu, Miao, et al.
Publicado: (2008)

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
por: Gaffo, Angelo L, et al.
Publicado: (2010)

Febuxostat: A Novel Agent for Management of Hyperuricemia in Gout
por: Bisht, Manisha, et al.
Publicado: (2011)

Evaluation of NAG, NGAL, and KIM-1 as Prognostic Markers of the Initial Evolution of Kidney Transplantation
por: Tabernero, Guadalupe, et al.
Publicado: (2023)

Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

SAT-079 Renal Protective Effects Of Topiroxostat And Febuxostat In Hypertensives With Hyperuricemia.
por: Satoh, Fumitoshi, et al.
Publicado: (2019)

Urine NGAL as an early biomarker for diabetic kidney disease: accumulated evidence from observational studies
por: Tang, Xing-Yao, et al.
Publicado: (2019)

Serum KIM-1, NGAL, and NAG Levels and Correlation with the Diagnostic Value in Patients with Fracture Traumatic Shock
por: Jiang, Xiaoyan, et al.
Publicado: (2021)

Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia
por: Beara-Lasic, Lada, et al.
Publicado: (2010)

Retracted: Serum KIM-1, NGAL, and NAG Levels and Correlation with the Diagnostic Value in Patients with Fracture Traumatic Shock
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? – preliminary study
por: Pietrukaniec, Marta, et al.
Publicado: (2020)

Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
por: Sofue, Tadashi, et al.
Publicado: (2014)

Expression and Significance of KIM-1, NGAL, and HO-1 in Patients with Acute Kidney Injury After Cardiac Valve Replacement
por: Zhang, Bin, et al.
Publicado: (2023)

Development of a europium nanoparticles lateral flow immunoassay for NGAL detection in urine and diagnosis of acute kidney injury
por: Yin, Moli, et al.
Publicado: (2022)

Hydration Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-Analysis
por: Cai, Qiuping, et al.
Publicado: (2020)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
por: Kim, Sollip, et al.
Publicado: (2017)

Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in sera and urine of patients with kidney tumors
por: DI CARLO, ANGELINA
Publicado: (2013)

Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury
por: Lee, Ya-Jane, et al.
Publicado: (2012)

Urinary Biomarkers of Renal Injury KIM-1 and NGAL: Reference Intervals for Healthy Pediatric Population in Sri Lanka
por: De Silva, P. Mangala C. S., et al.
Publicado: (2021)

Impact of colloids or crystalloids in renal function assessed by NGAL and KIM-1 after hysterectomy: randomized controlled trial
por: Santos, Murillo G., et al.
Publicado: (2021)

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
por: Liao, Zhimin, et al.
Publicado: (2022)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
por: Siddiqui, Khalid, et al.
Publicado: (2020)

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
por: Li, Yanchun, et al.
Publicado: (2019)

Correction: Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury
por: Lee, Ya-Jane, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rgcu8dn6ak5ltff06h9bqf5n40